Suppose a pharmaceutical company conducted a clinical trial for a new drug targeting a specific condition and found that 90% of participants experienced significant improvement in symptoms after taking the medication. The company announced plans to seek approval for the drug from regulatory authorities based on the positive results of the trial.
Can we infer that "The new drug has shown no effectiveness in treating the targeted condition among participants"? Yes, no, or maybe?